Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-07

Clinical Trial Update: Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study investigates whether HRS9531 alters the pharmacokinetics of metformin in healthy adults, informing potential interaction considerations for T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS9531
  • metformin (metformin)

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED